title: Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review.
abstract: With the development of effective antiretroviral therapy, HIV-infected women are living longer and transitioning through menopause. The purpose of our study was to systematically examine the evidence that menopause is an additional risk predictor for osteoporosis and fractures in HIV-infected women. Electronic databases were searched for studies of low bone density or fractures in HIV-infected postmenopausal women. Studies that met the inclusion criteria (n = 10) were appraised using a validated quality assessment tool. The majority of studies were rated as good quality and the remaining were fair. The prevalence of osteoporosis reported in these studies ranged from 7.3% to 84% and 0.7% to 23% in HIV-infected and uninfected postmenopausal women, respectively. In the two qualifying studies, postmenopausal status was not a predictor of fractures in HIV-infected women. Findings suggest that HIV care providers should accurately assess postmenopausal status and modifiable risk factors for osteoporosis in all older HIV-infected women.
authors.forename: Yamnia I
authors.initials: YI
authors.lastname: Cortés
authors.forename: Michael T
authors.initials: MT
authors.lastname: Yin
authors.forename: Nancy K
authors.initials: NK
authors.lastname: Reame
mesh_terms: D000368:Aged; D019380:Anti-HIV Agents / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000139:chemically induced*; D058866:Osteoporotic Fractures / Q000139:chemically induced*; D017698:Postmenopause
chemical_list: D019380:Anti-HIV Agents
keywords: HIV; bone mineral density (BMD); fractures; menopause